Tapping Into Immunotherapy’s Potential to Help More People
Webinar

Tapping into Immunotherapy’s Potential to Help More People

Discover what researchers have learned about varying immunotherapy response rates between patients with the same cancer types.

Share

 LIVE Symposium

Monday, April 22, 2024
11:30 AM - 2:30 PM Eastern Time

While some cancer immunotherapies are successful at treating malignancies and extending life expectancies, others fall short of their potential. Scientists examine how genetic variability and cellular evolution allow cancer to evade immunotherapy’s curative capacity for subsets of patients.

In this symposium brought to you by The Scientist, researchers will discuss how they uncover the factors that lead to varying immunotherapy response rates between patients with the same diseases.

Symposium program

11:30 AM – Introduction

11:40 AM – Immune surveillance in cancer evolution and why more mutations is not always better

Peter Westcott, PhD

12:10 PM – Germline modifiers of anti-tumor immunity and response to immune checkpoint blockade

Hannah Carter, PhD

12:40 PM – Advances in melanoma treatment: At the forefront of immune and targeted therapy discoveries

Ian Watson, PhD

1:10 PM – Gamma delta T cells in human cancer: should we care?

Yin Wu, MBPhD

1:40 PM - Open panel Q&A session
Deanna MacNeil from The Scientist's Creative Services Team will be joined by the entire panel in an open question and answer session where presenters will address questions posed by the audience.

Peter

Peter Westcott, PhD
Assistant Professor
Cancer Center
Cold Spring Harbor Laboratory

Hannah

Hannah Carter, PhD
Principal Investigator and Associate Professor
Department of Medicine
Division of Genomics and Precision Medicine
University of California, San Diego

Ian

Ian Watson, PhD
Member, Goodman Cancer Institute
Investigator, McGill University Health Center Research Institute
Associate Professor, Department of Biochemistry
McGill University

Yin Wu

Yin Wu, MBPhD
Wellcome Trust Clinician Scientist
School of Immunology and Microbial Sciences, King’s College London 
Department of Medical Oncology, Guy’s Hospital


Sponsored by

  • Lonza
  • 10X Genomics

Top Image Credit:

3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo